Overview
Ji Xu practices in Nanjing, China. Xu is highly rated in 4 conditions, according to our data. Their top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.
Their clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hemophagocytic Lymphohistiocytosis
- Non-Langerhans-Cell Histiocytosis
- Advanced
- HistiocytosisXu isAdvanced. Learn about Histiocytosis.
- Reticulohistiocytoma
- Experienced
- B-Cell LymphomaXu isExperienced. Learn about B-Cell Lymphoma.
- Castleman DiseaseXu isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- LeukemiaXu isExperienced. Learn about Leukemia.